Patent covers active pharmaceutical ingredient with protection until 2041 ANNAPOLIS, Md., Oct. 27, 2025 /PRNewswire/ -- Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the U.S. Patent and Trademark Office (USPTO) has granted a patent for the active pharmaceutical ingredient (API) in its lead candidate for atopic dermatitis (AD). The patent complements Alphyn's previously issued U.S. patent protecting its Zabalafin Hydrogel drug products and expands the company's broader intellectual property portfolio.

NEW COMPANY WILL BE A GLOBAL LEADER IN ADVANCED CATALYSTS AND ADDITIVES FOR THE REFINING AND PETROCHEMICAL INDUSTRIES NEW YORK, Oct. 27, 2025 /PRNewswire/ -- KPS Capital Partners, LP ("KPS") announced today that, through a newly formed affiliate, it has entered into a definitive agreement with Albemarle Corporation ("Albemarle") (NYSE: ALB) to acquire a controlling stake in Ketjen Corporation's refining catalyst solutions business (collectively, "Ketjen" or the "Company"). KPS and Albemarle, through affiliates, will own approximately 51% and 49% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. Albemarle will retain 100% of Ketjen Corporation's Performance Catalyst Solutions ("PCS") business. Completion of …

SANTIAGO, Chile, Oct. 27, 2025 /PRNewswire/ -- The highly anticipated 2025 IDF World Dairy Summit took place from October 20 to 23 in Santiago, Chile. Drawing global attention, the event served as an important barometer for the future of the dairy industry. Liu Chunxi, Chairman of the National Center of Technology Innovation for Dairy (NCTID) and Senior Executive President of Yili Group, was invited to the meeting of the IDF Task Force on the Paris Dairy Declaration on Sustainability, where he joined global dairy leaders, experts, and scholars in discussions on the industry's sustainable …

Managing everyday expenses feels tougher than ever. From rising grocery and utility costs to child care and housing, covering the basics can eat up an entire paycheck. GREENVILLE, S.C., Oct. 27, 2025 /PRNewswire/ -- With rising costs and paychecks that don't stretch as far as they used to, Americans continue to struggle as incomes haven't kept pace with inflation.

At Investor Day, outlines conviction in the JDE Peet's acquisition and robust plans to execute integration and separation Announces capital-efficient $7 billion strategic investment co-led by Apollo and KKR to reduce projected net leverage at acquisition close; sets targeted capital structure for each company at separation BURLINGTON, Mass. and FRISCO, Texas, Oct. 27, 2025 /PRNewswire/ -- Today, Keurig Dr Pepper (NASDAQ: KDP) announced new details about strategy, leadership and financing related to the acquisition of JDE Peet's and subsequent planned separation into two independent companies.

Albemarle Separately Signs Agreement to Sell its 50% Stake in Eurecat Joint Venture to Axens SA Combined transactions strengthen Albemarle's financial flexibility and drive greater portfolio focus Albemarle expects to receive total pre-tax cash proceeds of approximately $660 million for the sale of a 51% stake in Ketjen Corporation's refining catalyst solutions business and the sale of its 50% stake in the Eurecat JV upon close Both transactions are expected to close in the first half of 2026 pending regulatory approvals

HANGZHOU, China, Oct. 27, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; "the Company") today announced it has entered into a Strategic Cooperation Agreement with the SOLV Foundation, a cross-chain Bitcoin staking and structured finance platform boasting a total value locked (TVL) of US$2.8 billion. This collaboration underscores the Company's ambition as a Nasdaq-listed leader focused on building its treasury around Bitcoin as its primary digital asset holding.

LAUSANNE, Switzerland, Oct. 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in three upcoming investor conferences in November: Stephens Biotechnology Virtual Fireside Chats 2025Date: November 3, 2025Presentation Time: 12:00 p.m. ETFormat: Fireside ChatSpeaker: Ameet Mallik, Chief Executive OfficerLocation: VirtualThere will not be a replay or transcript of the call. To join the meeting or to obtain more information, please contact your Stephens representative.

SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) patients treated with paxalisib and to seek agency feedback on a potential regulatory pathway aligned with the FDA Oncology Center of Excellence's Project FrontRunner initiative.

PHOENIX, Oct. 27, 2025 /PRNewswire/ -- Xcellerant Ventures and Jetstream Venture Fund today celebrate the announcement of the John Shufeldt School of Medicine and Medical Engineering at Arizona State University (ASU), made possible through a transformational nine-figure gift from Dr. John Shufeldt. The new school, a central part of the ASU Health system, received preliminary accreditation from the Liaison Committee on Medical Education and will welcome its first class in 2026.

NEW YORK, Oct. 27, 2025 /PRNewswire/ -- Expert Consumers has named Qustodio the best parental control app of 2025, citing its powerful cross-platform features, recent innovations, and family-focused tools that support both safety and digital wellbeing. Best Parental Control App Qustodio : recognized for delivering privacy-conscious, easy-to-use software that empowers families to manage screen time, track location, filter web content, and monitor digital activity across devices.

The Irvine 1NH well was placed on production on October 14th and is currently producing at a strong initial average flow rate of 752 boe/d over two weeks, with no decline in production and a high oil cut of 82% Expansion of the 2025-2026 drilling program to begin across Johnson, Campbell, and Converse Counties, Wyoming with two additional wells expected to spud in the fourth quarter 2025 Three Crown is actively seeking reliable partners to participate in its Niobrara and Mowry drilling program for the remainder of 2025 and throughout 2026, including the Irvine 1NH

The two-day course gives home service business owners the confidence, tools and strategies to elevate their leadership and achieve lasting success EATONTOWN, N.J., Oct. 27, 2025 /PRNewswire/ -- CEO Warrior, a global business training, coaching and implementation organization for service business owners, is gearing up to host its immersive Warrior Trades Academy on Nov. 13-14 at its training facility in Eatontown, New Jersey.

VANCOUVER, BC, Oct. 27, 2025 /PRNewswire/ - Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) (FSE: 7AB) ("Eminent" or the "Company") is pleased to announce it has expanded its Hot Springs Range Project ("HSRP") in Humboldt County, Nevada (see Figures 1 and 2 for location) through the staking of a new claim package. With this expansion, HSRP now totals approximately 3,941 hectares. This addition complements Eminent's existing land position in what is emerging as a promising new gold district, located …

Through its Industry Forward® program, the trusted manufacturer gives $21,185 grant to raise awareness among young learners AMBLER, Pa., Oct. 27, 2025 /PRNewswire/ -- Bradford White Corporation, an industry-leading manufacturer of water heaters, boilers and storage tanks, announces the renewal of its partnership with Explore The Trades through its Industry Forward® program, marking the third consecutive year of collaboration.

The leading carpet and upholstery cleaning franchise's powerful cleaner has also received industry credentials ECOLOGO®, WoolSafe® and CleanSeal® ANN ARBOR, Mich., Oct. 27, 2025 /PRNewswire/ -- Chem-Dry®, the carpet and upholstery cleaning franchise leader, announces that its core cleaning solution, The Natural®, has obtained the prestigious EPA Safer choice label, certifying it as a product that meets the EPA's rigorous standards for human health, performance and sustainability. This is just the latest in a series of industry credentials earned by The Natural, which has previously obtained ECOLOGO®, WoolSafe® and CleanSeal® designations.

-- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen and BioInks as well as enable logistical efficiencies -- REHOVOT, Israel, Oct. 27, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen), today announced the expansion of its distribution footprint into North America through a new partnership with a U.S.-based logistics center. Scheduled to become operational this quarter, the logistics hub will provide full cGMP-compliant storage and distribution services and will serve as a clinical supply depot. This expansion will support CollPlant's growing customer base for its rhCollagen …

-- Conference Call Scheduled for Monday, November 3, 2025, at 8:00 a.m. ET -- NEWTON, Mass., Oct. 27, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report third quarter 2025 financial results on Monday, November 3, 2025. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Monday, November 3, 2025, to discuss the financial results and other company updates.

ROSH HA'AIN, Israel, Oct. 27, 2025 /PRNewswire/ -- Ceragon (NASDAQ: CRNT), a leading solutions provider of end-to-end wireless connectivity, announces that management will participate in the following investor conferences in November: Event: Craig-Hallum Alpha Select Conference Date: November 18, 2025 Location: New York City – Sheraton New York Times Square Hotel

-  ATNM-400 exhibits superior efficacy with 3-5x greater tumor growth inhibition compared to front line therapy osimertinib (EGFR TKI TAGRISSO®), second line therapy Dato-DXd (Trop-2 ADC DATROWAY®) and third line therapy amivantamab (EGFR-cMET bispecific RYBREVANT®) -  Combination of ATNM-400 and osimertinib resulted in complete tumor regression in 100% of tumor bearing animals; synergistic mechanism supported by increased ATNM-400 target antigen expression after EGFR inhibition with osimertinib